Zum Hauptinhalt springen
Kapitel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Chapter 12 Toxicity of essential oils

  • , , , , und
Veröffentlichen auch Sie bei De Gruyter Brill
Essential Oils
Ein Kapitel aus dem Buch Essential Oils

Abstract

Natural essential oils (EOs) and their compounds have substantially shown beneficial effects, but even with related herbal remedies that have been used for centuries. Still, uncontrolled practice can be devastating and can have consequences. A 100- to 1,000-fold increase in the concentration of EO components (often <0.01% yield) compared to the concentration of EO components in whole plants indicates that EOs are not equivalent to whole plants. All aspects of safety are now under scrutiny and new policies will rapidly prevent the trade and use of numerous EOs and cosmetics as well as their use in food. Some EOs are noxious if used in especially high doses, particularly when in use orally or by children and infants. It has been found that there is occurrence of several noxious components in several EOs that intrinsically makes them toxic, even utilized at very low concentrations. Though, further comprehensive studies are necessary to make sure the drug safety and efficacy before its authorization. The aim of this chapter documented the efficient available data associated with different aspects of toxicity, efficacy, and shelter problems of EOs. Further research is needed to evaluate and predict the toxicological characteristics of EOs via in vitro and in vivo methods. This study seeks to provide insight and/or update on the current state of the field through multiple reviews of specific aspects of the toxicity of EOs and their compounds as well as government focus. However, further research is needed to confirm the drug’s effectiveness and to evaluate the safety levels of the drugs proposed before approval.

Abstract

Natural essential oils (EOs) and their compounds have substantially shown beneficial effects, but even with related herbal remedies that have been used for centuries. Still, uncontrolled practice can be devastating and can have consequences. A 100- to 1,000-fold increase in the concentration of EO components (often <0.01% yield) compared to the concentration of EO components in whole plants indicates that EOs are not equivalent to whole plants. All aspects of safety are now under scrutiny and new policies will rapidly prevent the trade and use of numerous EOs and cosmetics as well as their use in food. Some EOs are noxious if used in especially high doses, particularly when in use orally or by children and infants. It has been found that there is occurrence of several noxious components in several EOs that intrinsically makes them toxic, even utilized at very low concentrations. Though, further comprehensive studies are necessary to make sure the drug safety and efficacy before its authorization. The aim of this chapter documented the efficient available data associated with different aspects of toxicity, efficacy, and shelter problems of EOs. Further research is needed to evaluate and predict the toxicological characteristics of EOs via in vitro and in vivo methods. This study seeks to provide insight and/or update on the current state of the field through multiple reviews of specific aspects of the toxicity of EOs and their compounds as well as government focus. However, further research is needed to confirm the drug’s effectiveness and to evaluate the safety levels of the drugs proposed before approval.

Heruntergeladen am 6.5.2026 von https://www.degruyterbrill.com/document/doi/10.1515/9783110791600-012/html?lang=de
Button zum nach oben scrollen